Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04183205 · ClinicalTrials.gov registry record · Phase 4
Predicting SSRI Efficacy in Veterans With PTSD
A Phase 4 study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT04183205: Clinical Trial Phase 4 study, sponsored by VA Office of Research and Development.
NCT04183205 is a Phase 4 study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04183205, a Phase 4 study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
This is a research study to examine the effectiveness of a brief screening method that may predict which people with posttraumatic stress disorder (PTSD) or depression are most likely to show a positive response to selective serotonin reuptake inhibitor (SSRI) medications. Participants will be recruited over approximately 5.25 years, until at least 94 participants complete the 17 week study.
Interventions
- DRUG Placebo
- DRUG sertraline
- DIAGNOSTIC_TEST LDAEP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-09-11 |
| Est. Completion | 2025-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04183205
The ClinicalTrials.gov registry entry for NCT04183205 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04183205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04183205 about?
NCT04183205 is a clinical study titled "Predicting SSRI Efficacy in Veterans With PTSD". This is a research study to examine the effectiveness of a brief screening method that may predict which people with posttraumatic stress disorder (PTSD) or depression are most likely to show a positive response to selective serotonin reuptake inhibitor (SSRI) medications. Participants will be recru...
What is the current status of trial NCT04183205?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2019-09-11. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT04183205?
The interventions under investigation include: Placebo (DRUG), sertraline (DRUG), LDAEP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04183205?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.